Cargando…
Metamizole-induced agranulocytosis (MIA): a mini review
Metamizole is an analgesic, antipyretic, and spasmolytic drug in Germany only approved for the treatment of severe pain or high fever that does not respond to other measures. In recent years, an increased use has been described among both adults and children, often against the approved indication. T...
Autores principales: | Tomidis Chatzimanouil, Markos K., Goppelt, Ines, Zeissig, Yvonne, Sachs, Ulrich J., Laass, Martin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435429/ https://www.ncbi.nlm.nih.gov/pubmed/37589909 http://dx.doi.org/10.1186/s40348-023-00160-8 |
Ejemplares similares
-
The involvement of specific t cells in the pathogenesis of metamizole-induced agranulocytosis
por: Adam, Jacqueline, et al.
Publicado: (2014) -
Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations
por: Cismaru, Anca Liliana, et al.
Publicado: (2020) -
A Case Report on Metamizole-Induced Agranulocytosis: Is the Benefit Worth the Risk?
por: Carvalho, Rita, et al.
Publicado: (2023) -
Fungal Periprosthetic Knee Joint Infection in a Patient with Metamizole-Induced Agranulocytosis
por: Oenning, Sebastian, et al.
Publicado: (2020) -
High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis
por: Cismaru, Anca Liliana, et al.
Publicado: (2020)